Trials / Unknown
UnknownNCT05227313
Double-Blind, Placebo-Controlled Trial of Eefooton in Patients With Chronic Kidney Disease
Evaluation Dietary Supplement" Eefooton" on the Quality of Life in Chronic Kidney Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This phase II study, 24-week, double-blind, study evaluated Eefooton's safety and efficacy for patients with CKD stage 3 to 4 Not on dialysis.
Detailed description
The purpose of this clinical observation and research is to evaluate the eGFR changes in the renal function of patients with chronic kidney disease combination the Eefooton oral solution and commonly used chemical drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Eefooton oral solution | Eefooton is extracted from Rhodiola, Huang Qi, American Ginseng, Dang Ginseng, and Ligustrum lucidum by biotechnology. It has immunomodulatory effects, anti-oxidation and anti-inflammatory effects, and regulates calcium metabolism. |
| DIETARY_SUPPLEMENT | Placebo oral solution | oral solution matched placebo |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2022-02-07
- Last updated
- 2022-03-02
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05227313. Inclusion in this directory is not an endorsement.